Results 281 to 290 of about 282,398 (356)
ABSTRACT Background Like tumor cells, cancer‐associated fibroblasts (CAFs) can enter the bloodstream and may function in systemic circulation. Methods Circulating CAFs (cCAFs) were isolated from the peripheral blood of head and neck squamous cell carcinoma (HNSCC) patients using CD45 depletion and detected by FAP expression using RT‐qPCR.
Kazuaki Chikamatsu+6 more
wiley +1 more source
Roles of MARCKSL1, MCM6, RFC4, and PLAU genes in esophageal cancer and their association with radiotherapy response. [PDF]
Zeng B+6 more
europepmc +1 more source
Current Advances in Immunotherapy Management of Esophageal Cancer. [PDF]
Pyreddy S+5 more
europepmc +1 more source
Causal association between modifiable risk factors and esophageal cancer: A Mendelian randomization study. [PDF]
Wang X+11 more
europepmc +1 more source
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li+7 more
wiley +1 more source
A nomogram model to predict postoperative delirium in esophageal cancer patients undergoing esophagectomy. [PDF]
Chen C, Wang J, Li Y.
europepmc +1 more source
What's New? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters+12 more
wiley +1 more source
Causal association of metabolic biomarkers and the risk of esophageal cancer: A 2-sample Mendelian randomization study. [PDF]
Ziyang L, Guo J, Du W.
europepmc +1 more source
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto+21 more
wiley +1 more source
Assessment of Chromosomal Aberrations and S-phase Fraction in Patients With Esophageal Cancer. [PDF]
Deora G+5 more
europepmc +1 more source